Reassessing therapeutic antibodies for neglected and tropical diseases.
In the past two decades there has been a significant expansion in the number of new therapeutic monoclonal antibodies (mAbs) that are approved by regulators. The discovery of these new medicines has been driven primarily by new approaches in inflammatory diseases and oncology, especially in immuno-o...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science (PLoS)
2020-01-01
|
| Colecção: | PLoS Neglected Tropical Diseases |
| Acesso em linha: | https://doi.org/10.1371/journal.pntd.0007860 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|